» Articles » PMID: 22759550

Recent Exposure to Antimicrobials and Carbapenem-resistant Enterobacteriaceae: the Role of Antimicrobial Stewardship

Abstract

Background: Carbapenem-resistant Enterobacteriaceae (CRE) are rapidly emerging worldwide. Control group selection is critically important when analyzing predictors of antimicrobial resistance. Focusing on modifiable risk factors can optimize prevention and resource expenditures. To identify specific predictors of CRE, patients with CRE were compared with 3 control groups: (1) patients with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, (2) patients with non-ESBL-containing Enterobacteriaceae, and (3) uninfected controls.

Design: Matched multivariable analyses.

Patients And Setting: Patients possessing CRE that were isolated at Detroit Medical Center from September 1, 2008, to August 31, 2009.

Methods: Patients were matched (1∶1 ratio) to the 3 sets of controls. Matching parameters included (1) bacteria type, (2) hospital/facility, (3) unit/clinic, (4) calendar year, and (5) time at risk (ie, from admission to culture). Matched multivariable analyses were conducted between uninfected controls and patients with CRE, ESBL, and non-ESBL Enterobacteriaceae. Models were also designed comparing patients with CRE to patients with ESBL, patients with non-ESBL Enterobacteriaceae, and all 3 non-CRE groups combined.

Results: Ninety-one unique patients with CRE were identified, and 6 matched models were constructed. Recent (less than 3 months) exposure to antibiotics was the only parameter that was consistently associated with CRE, regardless of the group to which CRE was compared, and was not independently associated with isolation of ESBL or non-ESBL Enterobacteriaceae.

Conclusions: Exposure to antibiotics within 3 months was an independent predictor that characterized patients with CRE isolation. As a result, antimicrobial stewardship efforts need to become a major focus of preventive interventions. Regulatory focus regarding appropriate antimicrobial use might decrease the detrimental effects of antibiotic misuse and spread of CRE.

Citing Articles

Point prevalence survey of antibiotic use in Mexican secondary care hospitals.

Zumaya-Estrada F, Alpuche-Aranda C, Huerta Icelo H, Neri-Estrada F, Calixto Silva V, Quiroz Escoriza H PLoS One. 2025; 20(1):e0315925.

PMID: 39752460 PMC: 11698459. DOI: 10.1371/journal.pone.0315925.


Multicomponent Approaches to Reduce Multidrug-Resistant Organisms in Critical Care: Determining the Ideal Strategy.

AlBahrani S, Saad M, Alqahtani J, Almoosa Z, Alabdulla M, Algezery M J Epidemiol Glob Health. 2024; 14(4):1371-1380.

PMID: 39347929 PMC: 11652424. DOI: 10.1007/s44197-024-00297-3.


Carbapenem-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.

Grome H, Grass J, Duffy N, Bulens S, Ansari U, Campbell D Emerg Infect Dis. 2024; 30(6):1104-1114.

PMID: 38781979 PMC: 11138972. DOI: 10.3201/eid3006.231734.


Prevalence and antimicrobial resistance profile of pathogens isolated from patients with urine tract infections admitted to a university hospital in a medium-sized Brazilian city.

Negri M, Lima B, Woloszynek R, Molina R, Germano C, Melo D Rev Inst Med Trop Sao Paulo. 2024; 66:e3.

PMID: 38198376 PMC: 10768654. DOI: 10.1590/S1678-9946202466003.


Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacterales vs Carbapenems: A Retrospective Study.

Kashihara E, Minoda Sada R, Tsugihashi Y, Obayashi H, Nakamura A, Abe N Open Forum Infect Dis. 2023; 10(10):ofad502.

PMID: 37901123 PMC: 10603591. DOI: 10.1093/ofid/ofad502.


References
1.
Schechner V, Kotlovsky T, Tarabeia J, Kazma M, Schwartz D, Navon-Venezia S . Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol. 2011; 32(5):497-503. DOI: 10.1086/659762. View

2.
Harris A, Samore M, Lipsitch M, Kaye K, Perencevich E, Carmeli Y . Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis. 2002; 34(12):1558-63. DOI: 10.1086/340533. View

3.
Marchaim D, Chopra T, Perez F, Hayakawa K, Lephart P, Bheemreddy S . Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center. Infect Control Hosp Epidemiol. 2011; 32(9):861-71. PMC: 4067763. DOI: 10.1086/661597. View

4.
Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R . Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009; 30(7):666-71. DOI: 10.1086/598244. View

5.
Mandell L, Wunderink R, Anzueto A, Bartlett J, Campbell G, Dean N . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2:S27-72. PMC: 7107997. DOI: 10.1086/511159. View